Cost component | All patients | HR+ patients | TNBC patients | |||
---|---|---|---|---|---|---|
Paclitaxel alone | Paclitaxel+ bevacizumab | Paclitaxel alone | Paclitaxel+ bevacizumab | Paclitaxel alone | Paclitaxel+ bevacizumab | |
Adverse events, EUR | 10 | 82 | 11 | 85 | 8 | 74 |
Progression cost, EUR | 22,588 | 29,319 | 24,700 | 35,752 | 14,871 | 17,980 |
Supportive care in PPS, EUR | 786 | 1951 | 868 | 2147 | 529 | 1411 |
Administration cost, EUR | 3542 | 4078 | 3772 | 4231 | 2982 | 3691 |
Drug cost, EUR | 0 | 18,885 | 0 | 19,590 | 0 | 17,091 |